
Sia YangSiaYang
China Associate, Capital Markets
Sia Yang is a China associate in the Corporate Department and is based in the firm’s Shanghai office. Her practice focuses on initial public offerings and transactions related to the Hong Kong capital market, as well as providing post-IPO compliance services.
Sia passed the bar examination in China in 2020 but does not hold a current practicing certificate in China. She is fluent in English and Mandarin.
East China University of Political Science and Law, LL.M., 2021
Shanghai University, LL.B., 2017
MedBot, a company dedicated to the research, development and commercialization of surgical robots, on its HK$1.5 billion global offering and listing on the Main Board of the Hong Kong Stock Exchange.*
CSCI as the sole sponsor on the HK$176 million global offering and listing of YZY Bio, a biotechnology company dedicated to developing bispecific antibody (BsAb)-based therapies to treat cancer-associated complications, on its HK$176 million global offering and listing on the Main Board of the Hong Kong Stock Exchange.*